Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection

Jordan E. Lake, Takara L. Stanley, Caroline M. Apovian, Shalendar Bhasin, Todd T Brown, Jaqueline Capeau, Judith S. Currier, Michael P. Dube, Julian Falutz, Steven K. Grinspoon, Giovanni Guaraldi, Esteban Martinez, Grace A. McComsey, Fred R. Sattler, Kristine M. Erlandson

Research output: Contribution to journalReview article

Abstract

Background. Obesity and lipohypertrophy are common in treated human immunodeficiency virus (HIV) infection and contribute to morbidity and mortality among HIV-infected adults on antiretroviral therapy (ART). Methods. We present a consensus opinion on the diagnosis, clinical consequences, and treatment of excess adiposity in adults with treated HIV infection. Results. Obesity and lipohypertrophy commonly occur among HIV-infected adults on ART and may have overlapping pathophysiologies and/or synergistic metabolic consequences. Traditional, HIV-specific, and ART-specific risk factors all contribute. The metabolic and inflammatory consequences of excess adiposity are critical drivers of non-AIDS events in this population. Although promising treatment strategies exist, further research is needed to better understand the pathophysiology and optimal treatment of obesity and lipohypertrophy in the modern ART era. Conclusions. Both generalized obesity and lipohypertrophy are prevalent among HIV-infected persons on ART. Aggressive diagnosis and management are key to the prevention and treatment of end-organ disease in this population and critical to the present and future health of HIV-infected persons.

Original languageEnglish (US)
Pages (from-to)1422-1429
Number of pages8
JournalClinical Infectious Diseases
Volume64
Issue number10
DOIs
StatePublished - May 15 2017

Fingerprint

Virus Diseases
Obesity
HIV
Adiposity
Therapeutics
Population
Morbidity
Mortality
Health
Research

Keywords

  • antiretroviral therapy
  • human immunodeficiency virus (HIV)
  • lipohypertrophy
  • obesity

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. / Lake, Jordan E.; Stanley, Takara L.; Apovian, Caroline M.; Bhasin, Shalendar; Brown, Todd T; Capeau, Jaqueline; Currier, Judith S.; Dube, Michael P.; Falutz, Julian; Grinspoon, Steven K.; Guaraldi, Giovanni; Martinez, Esteban; McComsey, Grace A.; Sattler, Fred R.; Erlandson, Kristine M.

In: Clinical Infectious Diseases, Vol. 64, No. 10, 15.05.2017, p. 1422-1429.

Research output: Contribution to journalReview article

Lake, JE, Stanley, TL, Apovian, CM, Bhasin, S, Brown, TT, Capeau, J, Currier, JS, Dube, MP, Falutz, J, Grinspoon, SK, Guaraldi, G, Martinez, E, McComsey, GA, Sattler, FR & Erlandson, KM 2017, 'Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection', Clinical Infectious Diseases, vol. 64, no. 10, pp. 1422-1429. https://doi.org/10.1093/cid/cix178
Lake, Jordan E. ; Stanley, Takara L. ; Apovian, Caroline M. ; Bhasin, Shalendar ; Brown, Todd T ; Capeau, Jaqueline ; Currier, Judith S. ; Dube, Michael P. ; Falutz, Julian ; Grinspoon, Steven K. ; Guaraldi, Giovanni ; Martinez, Esteban ; McComsey, Grace A. ; Sattler, Fred R. ; Erlandson, Kristine M. / Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. In: Clinical Infectious Diseases. 2017 ; Vol. 64, No. 10. pp. 1422-1429.
@article{0797a8908e7247ea8e0a4778e4fcc273,
title = "Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection",
abstract = "Background. Obesity and lipohypertrophy are common in treated human immunodeficiency virus (HIV) infection and contribute to morbidity and mortality among HIV-infected adults on antiretroviral therapy (ART). Methods. We present a consensus opinion on the diagnosis, clinical consequences, and treatment of excess adiposity in adults with treated HIV infection. Results. Obesity and lipohypertrophy commonly occur among HIV-infected adults on ART and may have overlapping pathophysiologies and/or synergistic metabolic consequences. Traditional, HIV-specific, and ART-specific risk factors all contribute. The metabolic and inflammatory consequences of excess adiposity are critical drivers of non-AIDS events in this population. Although promising treatment strategies exist, further research is needed to better understand the pathophysiology and optimal treatment of obesity and lipohypertrophy in the modern ART era. Conclusions. Both generalized obesity and lipohypertrophy are prevalent among HIV-infected persons on ART. Aggressive diagnosis and management are key to the prevention and treatment of end-organ disease in this population and critical to the present and future health of HIV-infected persons.",
keywords = "antiretroviral therapy, human immunodeficiency virus (HIV), lipohypertrophy, obesity",
author = "Lake, {Jordan E.} and Stanley, {Takara L.} and Apovian, {Caroline M.} and Shalendar Bhasin and Brown, {Todd T} and Jaqueline Capeau and Currier, {Judith S.} and Dube, {Michael P.} and Julian Falutz and Grinspoon, {Steven K.} and Giovanni Guaraldi and Esteban Martinez and McComsey, {Grace A.} and Sattler, {Fred R.} and Erlandson, {Kristine M.}",
year = "2017",
month = "5",
day = "15",
doi = "10.1093/cid/cix178",
language = "English (US)",
volume = "64",
pages = "1422--1429",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection

AU - Lake, Jordan E.

AU - Stanley, Takara L.

AU - Apovian, Caroline M.

AU - Bhasin, Shalendar

AU - Brown, Todd T

AU - Capeau, Jaqueline

AU - Currier, Judith S.

AU - Dube, Michael P.

AU - Falutz, Julian

AU - Grinspoon, Steven K.

AU - Guaraldi, Giovanni

AU - Martinez, Esteban

AU - McComsey, Grace A.

AU - Sattler, Fred R.

AU - Erlandson, Kristine M.

PY - 2017/5/15

Y1 - 2017/5/15

N2 - Background. Obesity and lipohypertrophy are common in treated human immunodeficiency virus (HIV) infection and contribute to morbidity and mortality among HIV-infected adults on antiretroviral therapy (ART). Methods. We present a consensus opinion on the diagnosis, clinical consequences, and treatment of excess adiposity in adults with treated HIV infection. Results. Obesity and lipohypertrophy commonly occur among HIV-infected adults on ART and may have overlapping pathophysiologies and/or synergistic metabolic consequences. Traditional, HIV-specific, and ART-specific risk factors all contribute. The metabolic and inflammatory consequences of excess adiposity are critical drivers of non-AIDS events in this population. Although promising treatment strategies exist, further research is needed to better understand the pathophysiology and optimal treatment of obesity and lipohypertrophy in the modern ART era. Conclusions. Both generalized obesity and lipohypertrophy are prevalent among HIV-infected persons on ART. Aggressive diagnosis and management are key to the prevention and treatment of end-organ disease in this population and critical to the present and future health of HIV-infected persons.

AB - Background. Obesity and lipohypertrophy are common in treated human immunodeficiency virus (HIV) infection and contribute to morbidity and mortality among HIV-infected adults on antiretroviral therapy (ART). Methods. We present a consensus opinion on the diagnosis, clinical consequences, and treatment of excess adiposity in adults with treated HIV infection. Results. Obesity and lipohypertrophy commonly occur among HIV-infected adults on ART and may have overlapping pathophysiologies and/or synergistic metabolic consequences. Traditional, HIV-specific, and ART-specific risk factors all contribute. The metabolic and inflammatory consequences of excess adiposity are critical drivers of non-AIDS events in this population. Although promising treatment strategies exist, further research is needed to better understand the pathophysiology and optimal treatment of obesity and lipohypertrophy in the modern ART era. Conclusions. Both generalized obesity and lipohypertrophy are prevalent among HIV-infected persons on ART. Aggressive diagnosis and management are key to the prevention and treatment of end-organ disease in this population and critical to the present and future health of HIV-infected persons.

KW - antiretroviral therapy

KW - human immunodeficiency virus (HIV)

KW - lipohypertrophy

KW - obesity

UR - http://www.scopus.com/inward/record.url?scp=85019104626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019104626&partnerID=8YFLogxK

U2 - 10.1093/cid/cix178

DO - 10.1093/cid/cix178

M3 - Review article

VL - 64

SP - 1422

EP - 1429

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 10

ER -